6-methyluracil has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gubaidullina, LM; Krylova, ES; Lenina, OA; Lushchekina, SV; Mukhamedyarov, MA; Petrov, KA; Petukhova, EO; Saifina, LF; Semenov, VE; Zueva, IV | 1 |
| Kharlamova, AD; Lushchekina, SV; Masson, P; Mikhailov, AS; Minnekhanova, OA; Mukhamedyarov, MA; Nikolsky, EE; Petrov, KA; Petukhova, EO; Podyachev, SN; Reznik, VS; Saifina, LF; Semenov, VE; Zobov, VV; Zueva, IV | 1 |
2 other study(ies) available for 6-methyluracil and Disease Models, Animal
| Article | Year |
|---|---|
Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Ammonium Compounds; Animals; Anions; Behavior, Animal; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Maze Learning; Memory Disorders; Mice; Molecular Docking Simulation; Scopolamine; Uracil | 2020 |
6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Transgenic; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Uracil | 2015 |